HomeTechLeadershipVentureFortune InsidersMost Powerful WomenAutomotiveCareersEnergy & EnvironmentExecutive TravelFinanceHealthinternationalRetailMarketsMagazineNewslettersVideosFortune Conferences

SORT BY

FILTER BY

also on other fortune lists

company facts

f500 stats

Fortune 500

Brand Index Methodology

The Morning Consult Brand Index is an indicator of brand strength among consumers. Each Fortune 500 company receives a score based on a ratio of favorable to unfavorable impressions among U.S. adults and its overall favorability. This ensures that a score takes into account how well-liked a company is among people who have an opinion of it without penalizing companies that are not consumer-facing.

Morning Consult polls thousands of adults across the country each week. The surveys are conducted online using large, established online survey vendors. The data is weighted to approximate a nationally representative sample based on age, race/ethnicity, gender, educational attainment, region, annual household income, home ownership status and marital status.

Martin Leissl — Bloomberg via Getty Images

69

Merck

MRK
 

Merck brought in $39.8 billion in 2016 global sales. The U.S. drug giant’s wide-ranging portfolio was crucial to that haul—but the company’s next-generation cancer immunotherapy treatment, Keytruda, is what really set it apart last year. The therapy bested rival Bristol-Myers Squibb’s competing Opdivo in the critical lung cancer space, according to clinical trial data, making it (and Merck) one of the most formidable players in the latest strike on cancer.

Looking for leads, investment insights, or competitive intelligence?

GET PREMIUM ACCESS

CEO

Kenneth C. Frazier

CEO Title

Chairman, President & Chief Executive Officer

Sector

Health Care

Industry

Pharmaceuticals

HQ Location

Kenilworth, NJ

Website

www.merck.com

Years on Fortune 500 List

23

Employees

68,000

Profile provided by S&P Global.
Merck is also featured in these fortune lists

World’s Most Admired Companies

#246

Global 500

Merck: Fortune 500 RANK HISTORY
 
 
Key Financials (Last Fiscal Year)
$ millions% change
Revenues ($M)$39,8070.8%
Profits ($M)$3,920.0-11.8%
Assets ($M)$95,377
Total Stockholder Equity ($M)$40,088
Market Value — as of March 31, 2017 ($M)$174,454
Profit Ratios
Profit as % of Revenues9.8%
Profits as % of Assets4.1%
Profits as % of Stockholder Equity9.8%
Earnings Per Share (Last Fiscal Year)
Earnings Per Share ($)1.41
EPS % Change (from 2015)-9.6%
EPS % Change (5 year annual rate)-6.9%
EPS % Change (10 year annual rate)-3.6%
Total Return
Total Return to Investors (2016)15.1%
Total Return to Investors (5 year, annualized)13.2%
Total Return to Investors (10 year, annualized)7.0%
STOCK QUOTE
()0.00 0.00 (0)
  • Previous Close:
  • Market Cap: NaNB
  • Next Earnings Date:
  • High:
  • Low:
  • 52 Week High:
  • 52 Week Low:
  • 52 Week Change %: 0.00
  • P/E Ratio: n/a
  • EPS:
  • Dividend Yield: n/a

News about Merck

68
70
Customer ServiceSite MapPrivacy PolicyFeedbackAd ChoicesAdvertisingYour California Privacy RightsReprints & PermissionsTerms of UseCareers
All products and services featured are based solely on editorial selection. FORTUNE may receive compensation for some links to products and services on this website.

Quotes delayed at least 15 minutes. Market data provided by Interactive Data. ETF and Mutual Fund data provided by Morningstar, Inc.. Dow Jones Terms & Conditions: http://www.djindexes.com/mdsidx/html/tandc/indexestandcs.html. S&P Index data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions
© 2017 Time Inc. All rights reserved. Fortune.com is a part of the Time.com network of sites.